Please Note:
This profile was automatically generated using 2 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 2 references found on the Internet. This information has not been verified. Learn more...
Web References
-
1. King's / IoP / Cognition Schizophrenia Imaging (CSI Lab)
weba.iop.kcl.ac.uk/iopweb/depa - [Cached]Published on: 11/22/2006 Last Visited: 11/22/2006
Dr Thomas Dannhauser
...
Dr Thomas Dannhauser is a honorary researcher at the Institute of Psychiatry at the Maudsley and specialist registrar in psychiatry and PhD student at UCL and Royal Free Hospitals. He studied medicine in South Africa and trained in psychiatry on the Bart's and The London scheme. His main research interests are the application of functional neuroimaging to characterise, monitor, and treat cognitive deficits seen in Alzheimer's dementia and its prodromal stages. At present he employs fMRI to study the effects of established and novel treatments on attention and memory in prodromal Alzheimer's disease. He has already studied the effects of a cholinesterase inhibitor (rivastigmine) and is currently studying the effects of near infrared spectroscopy (NIRS) neurofeedback training of prefrontal cortex. -
2. King's / IoP / CSI Lab (Cognition Schizophrenia Imaging)
www.iop.kcl.ac.uk/iopweb/depar - [Cached]Published on: 5/20/2006 Last Visited: 5/20/2006
Dr Thomas Dannhauser
Specialist Registrar, Psychiatry
PhD student
Dr Thomas Dannhauser is a honorary researcher at the Institute of Psychiatry at the Maudsley and specialist registrar in psychiatry and PhD student at UCL and RoyalFreeHospitals. He studied medicine in South Africa and trained in psychiatry on the Bart's and The London scheme. His main research interests are the application of functional neuroimaging to characterise, monitor, and treat cognitive deficits seen in Alzheimer's dementia and its prodromal stages. At present he employs fMRI to study the effects of established and novel treatments on attention and memory in prodromal Alzheimer's disease. He has already studied the effects of a cholinesterase inhibitor (rivastigmine) and is currently studying the effects of near infrared spectroscopy (NIRS) neurofeedback training of prefrontal cortex.
